Dubuque Bank & Trust’s Genmab GMAB Stock Holding History

Dubuque Bank & Trust’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-30,871	Closed	-$1.12M	–	236
2022 Q1	$1.12M	Sell	30,871 -2,868	-9%	-$98.4K	0.12%	93
2021 Q4	$1.33M	Sell	33,739 -2,057	-6%	-$85.8K	0.14%	91
2021 Q3	$1.56M	Sell	35,796 -922	-3%	-$41.4K	0.18%	86
2021 Q2	$1.5M	Sell	36,718 -2,119	-5%	-$81.8K	0.17%	90
2021 Q1	$1.27M	Sell	38,837 -2,371	-6%	-$89.2K	0.15%	92
2020 Q4	$1.68M	Sell	41,208 -17,985	-30%	-$672K	0.21%	80
2020 Q3	$2.17M	Sell	59,193 -4,710	-7%	-$170K	0.32%	73
2020 Q2	$2.17M	Sell	63,903 -8,360	-12%	-$228K	0.34%	70
2020 Q1	$1.53M	Sell	72,263 -8,117	-10%	-$181K	0.29%	73
2019 Q4	$1.79M	Buy	+80,380	New	+$1.75M	0.27%	73

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dubuque Bank & Trust's GMAB Position: Q2 2022 in Review

Dubuque Bank & Trust sold out of Genmab (GMAB) in Q2 2022, closing a stake of 30,871 shares — an estimated $1.12M sold.

Dubuque Bank & Trust first reported a position in GMAB in Q4 2019 and held it in 10 quarters. The position peaked at $2.17M in Q3 2020. 180 funds tracked by Wall St. Rank hold GMAB as of Q2 2022.

Dubuque Bank & Trust reported no remaining Genmab position as of Q2 2022 after selling out during the quarter.
Dubuque Bank & Trust sold 30,871 Genmab shares in Q2 2022, an estimated $1.12M.
Dubuque Bank & Trust first reported a position in Genmab in Q4 2019 and held it in 10 quarters.
Dubuque Bank & Trust's Genmab position peaked at $2.17M in Q3 2020.
180 funds tracked by Wall St. Rank held Genmab as of Q2 2022.

Based on Dubuque Bank & Trust's 13F filing for Q2 2022, filed 13 Jul 2022.